Block Copolymer Micelles in Nanomedicine Applications
Open accessThe DOI matches its Crossref record; 496 of the 496 references it cites were found in a registry or an index.
Abstract
Polymeric micelles are demonstrating high potential as nanomedicines capable of controlling the distribution and function of loaded bioactive agents in the body, effectively overcoming biological barriers, and various formulations are engaged in intensive preclinical and clinical testing. This Review focuses on polymeric micelles assembled through multimolecular interactions between block copolymers and the loaded drugs, proteins, or nucleic acids as translationable nanomedicines. The aspects involved in the design of successful micellar carriers are described in detail on the basis of the type of polymer/payload interaction, as well as the interplay of micelles with the biological interface, emphasizing on the chemistry and engineering of the block copolymers. By shaping these features, polymeric micelles have been propitious for delivering a wide range of therapeutics through effective sensing of targets in the body and adjustment of their properties in response to particular stimuli, modulating the activity of the loaded drugs at the targeted sites, even at the subcellular level. Finally, the future perspectives and imminent challenges for polymeric micelles as nanomedicines are discussed, anticipating to spur further innovations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEG-b-PBLA block copolymer was employed to form polymeric micelles for the physical encapsulation of doxorubicin [2].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [2]
In the citing paper
“The micelle formulation exhibited 15–20% of doxorubicin loading and a 57–70 nm of size distribution.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [2]
In the citing paper
“PEG-b-PBLA block copolymer was used to yield polymeric micelles for the physical encapsulation of doxorubicin [85]. The micelle preparation displayed 15–20% of doxorubicin loading and a 57–70 nm of size distribution.”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [85]
In the citing paper
“For example, micelles are suitable for the delivery of water-insoluble and amphiphilic drugs, and liposomes can increase the cellular uptake of a variety of drugs.14,15”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [15]
In the citing paper
“For example, micelles are suitable for the delivery of water-insoluble and amphiphilic drugs, and liposomes can increase the cellular uptake of a variety of drugs.14,15”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [15]
Citations
Cites
1 retracted
Elsabahy, M., Perron, M.-È., Bertrand, N., Yu, G.-E., & Leroux, J.-C. (2007) · Biomacromolecules · doi:10.1021/bm070226v · Cited by 83
RetractedNanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Photodynamic therapy for cancer
Dolmans, D. E. J. G. J., Fukumura, D., & Jain, R. K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1071 · Cited by 6,758
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Research works printed but not linked: 4
- Kabanov, 2002, Pluronic® Block Copolymers as Novel Polymer Therapeutics for Drug and Gene Delivery, J. Controlled Release, 82, 189, 10.1016/S0168-3659(02)00009-3 · DOI · Paper page
- Wiley, 2013, Transcytosis and Brain Uptake of Transferrin-Containing Nanoparticles by Tuning Avidity to Transferrin Receptor, Proc. Natl. Acad. Sci. U. S. A., 110, 8662, 10.1073/pnas.1307152110 · DOI · Paper page
- Uchida, 2013, In vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle, PLoS One, 8, e56220, 10.1371/journal.pone.0056220 · DOI
- Fang, 2011, The EPR Effect: Unique Features of Tumor Blood Vessels for Drug Delivery, Factors Involved, and Limitations and Augmentation of the Effect, Adv. Drug Delivery Rev., 63, 136, 10.1016/j.addr.2010.04.009 · DOI · Paper page
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Smart nanoparticles for cancer therapy
Sun, L., Liu, H., Ye, Y., Lei, Y., Islam, R., Tan, S., Tong, R., Miao, Y.-B., & Cai, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01642-x · Cited by 1,073
“14,15 2) Smart nanoparticles based on speci fi c materials and components of nanocarriers can respond to external and internal stimuli, such as enzyme, pH, temperature, as well as optical and magnetic regulation, etc. 3) Another embodiment of smart nanoparticles is their tumor targeting…”
BackgroundStimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics
Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 830
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
“Biocompatible polymers have been extensively employed in pharmaceutical science as excipients for traditional pharmaceutical formulations and more recently in nanomedicines for enhancing therapeutic outcomes of potent drugs [1,2].”
BackgroundMethodInfluentialImproving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Self-citationCurrent advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis
Das, S. S., Bharadwaj, P., Bilal, M., Barani, M., Rahdar, A., Taboada, P., Bungau, S., & Kyzas, G. Z. (2020) · Polymers · doi:10.3390/polym12061397 · Cited by 581
Nanoparticle Characterization: What to Measure?
Modena, M. M., Rühle, B., Burg, T. P., & Wuttke, S. (2019) · Advanced Materials · doi:10.1002/adma.201901556 · Cited by 498
pH-responsive polymer nanoparticles for drug delivery
Deirram, N., Zhang, C., Kermaniyan, S. S., Johnston, A. P. R., & Such, G. K. (2019) · Macromolecular Rapid Communications · doi:10.1002/marc.201800917 · Cited by 531
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Kwon, S., Ko, H., You, D. G., Kataoka, K., & Park, J. H. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00136 · Cited by 370
Self-citationAliphatic Polycarbonates from Cyclic Carbonate Monomers and Their Application as Biomaterials
Yu, W., Maynard, E., Chiaradia, V., Arno, M. C., & Dove, A. P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00883 · Cited by 355
Lu, H., Zhang, S., Wang, J., & Chen, Q. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.783831 · Cited by 334
“Polymer Micelles Polymer micelles are a class of nano-colloids, which can be formed by self-assembly of amphiphilic block copolymers in aqueous solution (52).”
BackgroundCurrent approaches of nanomedicines in the market and various stage of clinical translation
Shan, X., Gong, X., Li, J., Wen, J., Li, Y., & Zhang, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.025 · Cited by 335
Kuperkar, K., Patel, D., Atanase, L. I., & Bahadur, P. (2022) · Polymers · doi:10.3390/polym14214702 · Cited by 333
Ligand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350
Self-citationNanotechnology-based antiviral therapeutics
Chakravarty, M., & Vora, A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00818-0 · Cited by 334
Artificial exosomes for translational nanomedicine
Li, Y.-J., Wu, J.-Y., Liu, J., Xu, W., Qiu, X., Huang, S., Hu, X.-B., & Xiang, D.-X. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00986-2 · Cited by 303
“Introduction In recent decades, synthetic nanoparticles (NPs) including liposomes [1], micelles [2], dendrimers [3], nanocapsules [4], nanodiamonds [5], nanosponges [6], nanoemulsions [7] and self-assembled peptides [8] have been extensively studied for nanomedicine, particularly for targeted cancer therapy.”
BackgroundDesai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
pH ‐responsive polymers for drug delivery: Trends and opportunities
Singh, J., & Nayak, P. (2023) · Journal of Polymer Science · doi:10.1002/pol.20230403 · Cited by 327
Radiolabelling of nanomaterials for medical imaging and therapy
Pellico, J., Gawne, P. J., & T. M. de Rosales, R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00384k · Cited by 304
Recent progress of magnetic nanoparticles in biomedical applications: A review
Anik, M. I., Hossain, M. K., Hossain, I., Mahfuz, A. M. U. B., Rahman, M. T., & Ahmed, I. (2021) · Nano Select · doi:10.1002/nano.202000162 · Cited by 300
Lammers, T. (2024) · Advanced Materials · doi:10.1002/adma.202312169 · Cited by 290
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Self-citationLi, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Self-citationFan, Y., Liu, S., Yi, Y., Rong, H., & Zhang, J. (2021) · ACS Nano · doi:10.1021/acsnano.0c06962 · Cited by 276
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Su, S., & M. Kang, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090837 · Cited by 259
Block copolymer solution self‐assembly: Recent advances, emerging trends, and applications
Karayianni, M., & Pispas, S. (2021) · Journal of Polymer Science · doi:10.1002/pol.20210430 · Cited by 257
Photodynamic therapy: photosensitizers and nanostructures
Escudero, A., Carrillo-Carrión, C., Castillejos, M. C., Romero-Ben, E., Rosales-Barrios, C., & Khiar, N. (2021) · Materials Chemistry Frontiers · doi:10.1039/d0qm00922a · Cited by 252
Smart drug delivery systems for precise cancer therapy
Wang, X., Li, C., Wang, Y., Chen, H., Zhang, X., Luo, C., Zhou, W., Li, L., Teng, L., Yu, H., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.013 · Cited by 233
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
Qiu, C., Xia, F., Zhang, J., Shi, Q., Meng, Y., Wang, C., Pang, H., Gu, L., Xu, C., Guo, Q., et al. (2023) · Research · doi:10.34133/research.0148 · Cited by 224
“Studies have reported that the buffering capacity of some polymer-based delivery systems was insufficient to achieve endosomal escape during their transport from endosomes/lysosomes to the cytoplsm [54,102].”
BackgroundLiu, J., Cabral, H., & Mi, P. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115239 · Cited by 229
Self-citationSuperparamagnetic nanoparticles for biomedical applications
Xiao, Y., & Du, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/c9tb01955c · Cited by 237
Wang, Z., Ju, Y., Ali, Z., Yin, H., Sheng, F., Lin, J., Wang, B., & Hou, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-12142-4 · Cited by 232
Recent Trends in Advanced Polymer Materials in Agriculture Related Applications
Sikder, A., Pearce, A. K., Parkinson, S. J., Napier, R., & O’Reilly, R. K. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.0c00982 · Cited by 224
Linear Block Copolymer Synthesis
Dau, H., Jones, G. R., Tsogtgerel, E., Nguyen, D., Keyes, A., Liu, Y.-S., Rauf, H., Ordonez, E., Puchelle, V., Basbug Alhan, H., et al. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00189 · Cited by 210
Yin, W., Ke, W., Chen, W., Xi, L., Zhou, Q., Mukerabigwi, J. F., & Ge, Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.032 · Cited by 202
Helical polymers for biological and medical applications
Leigh, T., & Fernandez-Trillo, P. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0180-5 · Cited by 192
Ding, X., Wang, A., Tong, W., & Xu, F. (2019) · Small · doi:10.1002/smll.201900999 · Cited by 193
Polymer‐Based mRNA Delivery Strategies for Advanced Therapies
Yang, W., Mixich, L., Boonstra, E., & Cabral, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202688 · Cited by 186
Self-citationFang, K., Wang, R., Zhang, H., Zhou, L., Xu, T., Xiao, Y., Zhou, Y., Gao, G., Chen, J., Liu, D., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13009 · Cited by 189
Xie, Z., Liang, S., Cai, X., Ding, B., Huang, S., Hou, Z., Ma, P., Cheng, Z., & Lin, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10685 · Cited by 187
Protein Encapsulation Using Complex Coacervates: What Nature Has to Teach Us
Blocher McTigue, W. C., & Perry, S. L. (2020) · Small · doi:10.1002/smll.201907671 · Cited by 183
A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines
Yan, L., Zhao, F., Wang, J., Zu, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805391 · Cited by 183
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Zhen, W., Weichselbaum, R. R., & Lin, W. (2023) · Advanced Materials · doi:10.1002/adma.202206370 · Cited by 177
Targeting cartilage EGFR pathway for osteoarthritis treatment
Wei, Y., Luo, L., Gui, T., Yu, F., Yan, L., Yao, L., Zhong, L., Yu, W., Han, B., Patel, J. M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3946 · Cited by 178
“Compared to other drug nanocarriers (42), the polymeric NPs provide several advantages, including their relatively small size and the use of similar formulations in different preclinical and clinical studies.”
BackgroundNanotechnology-based mRNA vaccines
Chen, S., Huang, X., Xue, Y., Álvarez-Benedicto, E., Shi, Y., Chen, W., Koo, S., Siegwart, D. J., Dong, Y., & Tao, W. (2023) · Nature Reviews Methods Primers · doi:10.1038/s43586-023-00246-7 · Cited by 165
Deng, S., Li, X., Liu, S., Chen, J., Li, M., Chew, S. Y., Leong, K. W., & Cheng, D. (2020) · Science Advances · doi:10.1126/sciadv.abb4005 · Cited by 169
“Combined therapy involving codelivery of two or more drugs is a common tumor treatment strategy ( 19 – 22 ), but codelivery of Cas9 with small-molecular drugs has not been investigated thoroughly.”
Liu, N., Zhou, L., & Wu, Z.-Q. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00489 · Cited by 167
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Tanabe, S., Quader, S., Cabral, H., & Ono, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00904 · Cited by 161
“Nanomedicine has the potential for developing unprecedented therapies by controlling drug functions in a spatiotemporal manner (Cabral et al., 2018), which allows for effective targeting to subpopulations in tumor tissues, as well as intracellular therapeutic targets.”
BackgroundSelf-citationRecent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
“PEG-b-PBLA block copolymer was used to yield polymeric micelles for the physical encapsulation of doxorubicin [85].”
MethodStrategies for non-viral vectors targeting organs beyond the liver
Kim, J., Eygeris, Y., Ryals, R. C., Jozić, A., & Sahay, G. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01563-4 · Cited by 171
“Polyplex micelles also can incorporate both hydrophobic parts and hydrophilic parts, allowing for efficient encapsulation and controlled release of nucleic acids 28,29 .”
Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles
Ahmad, A., Khan, J. M., & Haque, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.02.012 · Cited by 155
Machtakova, M., Thérien‐Aubin, H., & Landfester, K. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00686j · Cited by 158
Quader, S., Kataoka, K., & Cabral, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114115 · Cited by 155
Self-citationStimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments
Sun, T., & Jiang, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114773 · Cited by 147
Nanomedicine-Based Approaches for mRNA Delivery
Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139
Self-citationVarlas, S., Lawrenson, S. B., Arkinstall, L. A., O’Reilly, R. K., & Foster, J. C. (2020) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2020.101278 · Cited by 139
The roles of polymers in mRNA delivery
Huang, P., Deng, H., Zhou, Y., & Chen, X. S. (2022) · Matter · doi:10.1016/j.matt.2022.03.006 · Cited by 134
Poly(ethylene glycol) alternatives in biomedical applications
Yao, X., Qi, C., Sun, C., Huo, F., & Jiang, X. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101738 · Cited by 133
Yi, Y., Kim, H. J., Zheng, M., Mi, P., Naito, M., Kim, B. S., Min, H. S., Hayashi, K., Perche, F., Toh, K., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.006 · Cited by 135
Self-citationCyclodextrin-based polymer materials: From controlled synthesis to applications
Yao, X., Huang, P., & Nie, Z. (2019) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2019.03.004 · Cited by 134
Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy
Zhen, W., An, S., Wang, S., Hu, W., Li, Y., Jiang, X., & Li, J. (2021) · Advanced Materials · doi:10.1002/adma.202101572 · Cited by 129
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 155
Self-assembly of protein-polymer conjugates for drug delivery
Stevens, C. A., Kaur, K., & Klok, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.002 · Cited by 133
Xie, Z., Cai, X., Sun, C., Liang, S., Shao, S., Huang, S., Cheng, Z., Pang, M., Xing, B., Kheraif, A. A. A., et al. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b04321 · Cited by 125
Understanding the Interaction of Polyelectrolyte Architectures with Proteins and Biosystems
Achazi, K., Haag, R., Ballauff, M., Dernedde, J., Kizhakkedathu, J. N., Maysinger, D., & Multhaup, G. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202006457 · Cited by 123
Molecular Design of Chemically Fueled Peptide–Polyelectrolyte Coacervate-Based Assemblies
Späth, F., Donau, C., Bergmann, A. M., Kränzlein, M., Synatschke, C. V., Rieger, B., & Boekhoven, J. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c01148 · Cited by 124
Developments in nanotechnology approaches for the treatment of solid tumors
Venturini, J., Chakraborty, A., Baysal, M. A., & Tsimberidou, A. M. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00656-1 · Cited by 129
“However, their formation and stability are closely dependent on the critical micelle concentration, which must be low to ensure resistance to dilution in physiological conditions, thereby prolonging their circulation time and effectiveness [75].”
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Zhu, Y., Yu, X., Thamphiwatana, S., Zheng, Y., & Pang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.010 · Cited by 118
Xie, J., Gonzalez‐Carter, D., Tockary, T. A., Nakamura, N., Xue, Y., Nakakido, M., Akiba, H., Dirisala, A., Liu, X., Toh, K., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09991 · Cited by 122
Self-citationTumor-Targeted Nanomedicine for Immunotherapy
Cabral, H., Kinoh, H., & Kataoka, K. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00518 · Cited by 120
Self-citationZou, Z., Han, L., Xu, G., Hu, Y., Zhang, W., & Tian, K. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417422 · Cited by 125
Luo, L., Xu, F., Peng, H., Luo, Y., Tian, X., Battaglia, G., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.017 · Cited by 114
“endocytosis, in which nano-sized DDS can detach a small piece of the bilayer membrane of cancer cells and the piece wraps the DDS into the cells [12].”
BackgroundProtein–Polyelectrolyte Complexes and Micellar Assemblies
Gao, S., Holkar, A., & Srivastava, S. (2019) · Polymers · doi:10.3390/polym11071097 · Cited by 118
Designing of Nanomaterials-Based Enzymatic Biosensors: Synthesis, Properties, and Applications
Cavalcante, F. T. T., Falcão, Í. R. D. A., Souza, J. E. D. S., Rocha, T. G., de Sousa, I. G., Cavalcante, A. L. G., de Oliveira, A. L. B., de Souza, M. C. M., & dos Santos, J. C. S. (2021) · Electrochem · doi:10.3390/electrochem2010012 · Cited by 111
Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics
Huang, D., He, B., & Mi, P. (2019) · Biomaterials Science · doi:10.1039/c9bm00831d · Cited by 109
Package delivered: folate receptor-mediated transporters in cancer therapy and diagnosis
Ahmadi, M., Ritter, C. A., von Woedtke, T., Bekeschus, S., & Wende, K. (2024) · Chemical Science · doi:10.1039/d3sc05539f · Cited by 108
Recent Advances in Poly(α-L-glutamic acid)-Based Nanomaterials for Drug Delivery
Zhang, Y., Song, W., Lu, Y., Xu, Y., Wang, C., Yu, D., & Kim, I. (2022) · Biomolecules · doi:10.3390/biom12050636 · Cited by 108
“Although chemotherapy has gained enormous achievements in cancer treatment, the non-specific drug distributioninduced systemic side effects of anticancer drugs are still a Gordian knot [1,2].”
BackgroundPhysically stimulus-responsive nanoparticles for therapy and diagnosis
Farjadian, F., Ghasemi, S., Akbarian, M., Hoseini‐Ghahfarokhi, M., Moghoofei, M., & Doroudian, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.952675 · Cited by 110
“It protects the drugs against the external medium, whereas the shorter hydrophobic interior part improves the loading of the lipophilic therapeutic agents such as some drugs, genes, and proteins (Movassaghian et al., 2015; Cabral et al., 2018; Hanafy et al., 2018).”
BackgroundExploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine
Wang, Q., Atluri, K., Tiwari, A. K., & Babu, R. J. (2023) · Pharmaceuticals · doi:10.3390/ph16030433 · Cited by 113
Wang, J., Zhao, W., Zhang, Z., Liu, X., Xie, T., Wang, L., Xue, Y., & Zhang, Y. (2024) · Advanced Materials · doi:10.1002/adma.202308915 · Cited by 115
Kaur, J., Mishra, V. K., Singh, S. K., Gulati, M., Kapoor, B., Chellappan, D. K., Gupta, G., Dureja, H., Anand, K., Dua, K., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.014 · Cited by 106
Zong, S., Wen, H., Lv, H., Li, T., Tang, R., Liu, L., Jiang, J., Wang, S., & Duan, J. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118943 · Cited by 102
Rajdev, P., & Ghosh, S. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b09441 · Cited by 101
Iurciuc, C. E., Cretan, M. S., Purcar, V., Popa, M., Daraba, O. M., Atanase, L. I., & Ochiuz, L. (2020) · Polymers · doi:10.3390/polym12071450 · Cited by 101
“These micellar structures have proven their ability to include and to deliver poorly water-soluble drugs, improve drug stability, and have good penetration and site-specificity, leading to an enhanced therapeutic efficacy [8].”
BackgroundAbbasi, S., Uchida, S., Toh, K., Tockary, T. A., Dirisala, A., Hayashi, K., Fukushima, S., & Kataoka, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.026 · Cited by 103
Self-citationOrnelas, C., & Astruc, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082044 · Cited by 106
Antimicrobial Activity Enhancers: Towards Smart Delivery of Antimicrobial Agents
Skwarczyński, M., Bashiri, S., Yuan, Y., Ziora, Z. M., Nabil, O., Masuda, K., Khongkow, M., Rimsueb, N., Cabral, H., Ruktanonchai, U., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11030412 · Cited by 102
Self-citationNew Advances in Biomedical Application of Polymeric Micelles
Figueiras, A., Domingues, C., Jarak, I., Santos, A. I., Parra, A., Pais, A. A. C. C., Alvarez‐Lorenzo, C., Concheiro, Á., Kabanov, A. V., Cabral, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081700 · Cited by 100
Self-citationAdvanced application of nanotechnology in active constituents of Traditional Chinese Medicines
Qiu, C., Zhang, J. Z., Wu, B., Xu, C. C., Pang, H. H., Tu, Q., Lu, Y. Q., Guo, Q. Y., Xia, F., & Wang, J. G. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02165-x · Cited by 106
“4) [331].”
Suzuki, K., Miura, Y., Mochida, Y., Miyazaki, T., Toh, K., Anraku, Y., Melo, V. A., Liu, X., Ishii, T., Nagano, O., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.021 · Cited by 101
Self-citationPolymeric micelles for pulmonary drug delivery: a comprehensive review
Pham, D. T., Chokamonsirikun, A., Phattaravorakarn, V., & Tiyaboonchai, W. (2020) · Journal of Materials Science · doi:10.1007/s10853-020-05361-4 · Cited by 100
“With the exception of PAA, all other polymers are clinically approved for drug delivery usage [22].”
BackgroundEvolution of nanomedicine formulations for targeted delivery and controlled release
Puri, S., Mazza, M., Roy, G., England, R., Zhou, L., Nourian, S., & Subramony, J. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114962 · Cited by 102
Gu, X., Wei, Y., Fan, Q., Sun, H., Cheng, R., Zhong, Z., & Deng, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.005 · Cited by 93
Advances in non-covalent crosslinked polymer micelles for biomedical applications
Lin, M., Dai, Y., Xia, F., & Zhang, X. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111626 · Cited by 97
Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery
Mollé, L. M., Smyth, C. H., Yuen, D., & Johnston, A. P. R. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1809 · Cited by 95
“While PIC micelles can be readily engineered with different properties, using these nanoparticles for nucleic acid delivery still requires improvement with clearance and degradation rates significantly higher for nucleic acid loaded PIC micelles than unloaded PIC micelles (Cabral et al., 2018).”
BackgroundWang, Y., Tao, B., Wan, Y., Sun, Y. L., Wang, L., Sun, J., & Li, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110372 · Cited by 91
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Guo, J., Zou, Y., & Huang, L. (2023) · Small Methods · doi:10.1002/smtd.202201307 · Cited by 94
Uchida, S., & Kataoka, K. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36614 · Cited by 97
Self-citation
Metadata
- Authors
- Cabral, H., Miyata, K., Osada, K., & Kataoka, K.
- Affiliations
- The University of Tokyo (JP)
- Innovation Center of NanoMedicine (JP)
- Corresponding author
- Kataoka, Kazunori
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-06-29
- Volume
- 118
- Issue
- 14
- Pages
- 6844-6892
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2811501377
- Cited by
- 1,309
- References
- 494
- Citations by year
- 2026: 92 · 2025: 166 · 2024: 147 · 2023: 190 · 2022: 192 · 2021: 206 · 2020: 181 · 2019: 119 · 2018: 16
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Chemical Reviews (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Agency for Medical Research and Development (16cm0106202h0001)
- Japan Society for the Promotion of Science (JP16H03179, JP25750172)
- Ministry of Education, Culture, Sports, Science and Technology (NA)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polymeric micelles, block copolymers, nanomedicine, drug delivery, stimuli-responsive drug release, targeted drug delivery, subcellular drug delivery
- MeSH terms
- Drug Carriers, Drug Compounding, Pharmaceutical Preparations, Humans, Micelles, Oligonucleotides, Polymers, Nanomedicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.